ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,004, issued on May 27, was assigned to VISION SOLUTIONS LLC (Tucson, Ariz.).
"Ophthalmic formulations and methods of use" was invented by Brian A. Hunter (Tucson, Ariz.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Feline herpesvirus (FHV-1) is a highly contagious virus affecting domestic and wild felines and is the leading cause of corneal disease and conjunctivitis in cats. Thus, provided herein is topical ophthalmic formulation for treating FHV-1, comprising L-lysine and a second therapeutic agent, such as osha root (e.g., ligustilide). The formulation enables direct and concentrated delivery to the ocular surface, which is believed to enhance e...